Myomo (MYO) Current Deferred Revenue (2016 - 2025)
Myomo filings provide 10 years of Current Deferred Revenue readings, the most recent being $134750.0 for Q3 2025.
- On a quarterly basis, Current Deferred Revenue rose 321.48% to $134750.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $134750.0, a 321.48% increase, with the full-year FY2024 number at $83100.0, up 876.5% from a year prior.
- Current Deferred Revenue hit $134750.0 in Q3 2025 for Myomo, up from $108780.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $134750.0 in Q3 2025 to a low of $747.0 in Q1 2023.
- Median Current Deferred Revenue over the past 5 years was $10262.5 (2023), compared with a mean of $33137.3.
- Biggest five-year swings in Current Deferred Revenue: crashed 94.51% in 2021 and later surged 1508.43% in 2024.
- Myomo's Current Deferred Revenue stood at $1500.0 in 2021, then skyrocketed by 1313.33% to $21200.0 in 2022, then tumbled by 59.86% to $8510.0 in 2023, then skyrocketed by 876.5% to $83100.0 in 2024, then soared by 62.15% to $134750.0 in 2025.
- The last three reported values for Current Deferred Revenue were $134750.0 (Q3 2025), $108780.0 (Q2 2025), and $129900.0 (Q1 2025) per Business Quant data.